Order of the National Green Tribunal in the matter of News Item titled "2 killed in blast at illegal cracker unit in Thanjavur appearing in The Hindu dated 19.05.2025". The application is registered suo-motu on the basis of the news item titled 2 killed in blast at illegal cracker unit …
Several drug manufacturers accused of colluding with the sector regulator and medical experts to allegedly violate approval norms have denied the charges, claiming that the local authority acted independently. The Parliamentary Standing Committee on Health and Family Welfare had on Tuesday released a scathing report, alleging “apparent nexus between the …
Under attack over the functioning of the Central Drugs Standard Control Organisation (CDSCO), the Ministry of Health and Family Welfare today claimed to have “already taken several steps” to plug the loopholes in the system. Reacting to a standing committee report on the functioning of CDSCO, tabled in Parliament yesterday, …
Nexus To Get Approvals: MPs’ Panel New Delhi: Some drug companies seem to have been writing scientific recommendations of their own products and submitting them to the Drug Controller General of India after getting them endorsed by top doctors, according to a report by the parliamentary standing committee on health …
‘Purpose Not Being Served As Towns Aren’t Ethnically Diverse’ New Delhi: Smaller cities seem to have become prime target for drug trials. While pharma companies have claimed over the last few years that most of their drug trials were taking place in “cosmopolitan towns” which have a heterogeneous population, comprising …
German pharmaceutical company Bayer AG has formally lodged a challenge against a landmark Indian ruling that allowed a domestic generic drug-maker to produce a low-cost version of an anti-cancer drug for the Indian market. The appeal was filed on Friday 4 May with India's Intellectual Property Appellate Board.
PANJIM: The Manohar Parrikar-led government’s decision to hike power tariff has not gone well with the industries in the state. The apex trade body, Goa Chamber of Commerce and Industry (GCCI) has claimed that the hike will affect as many as 140 industries, mostly from steel and pharma sector, largely …
NEW DELHI: Officials in Central Drugs Standard Control Organization (CDSCO) seem to have "colluded with private interests" to get the controversial drug Letrozole approved in India "in a clear violation of laws" for use against infertility. Now, the parliamentary standing committee on health and family welfare has asked the Union …
The government has recently stopped giving permission to foreign companies and overseas investors to buy into Indian drugmakers till clear guidelines regarding foreign direct investment in the sector are finalised. The Foreign Investment Promotion Board (FIPB), the nodal agency that approves investments in India, deferred four proposals at its March …
The Bombay High Court last week has asked the Brihanmumbai Municipal Corporation (BMC) to give a fresh hearing to pharmaceutical company GlaxoSmithKline involving a land dispute in Worli. Ruling in favour of the company, a division bench of Justice S J Vazifdar and Justice A R Joshi questioned why the …
The enormity of pollution due to pharmaceuticals in India has caught the attention of researchers all over the world. This was due to the near extinction of vultures in the Indian subcontinent in the 1990s caused by diclofenac and a recent study in 2007 by Swedish scientists on pharmaceutical effluents …
Liberalisation measures in the pharmaceutical sector have brought about major changes in the industrial licensing policy, import restrictions, foreign direct investment and production controls. It was feared that firms would shift from indigenous production to imports, especially of bulk drugs, and this concern was aggravated with the change in the …
In June 2008, when Japanese drugmaker Daiichi Sankyo acquired Ranbaxy Laboratories, Daiichi’s chief executive Takashi Shoda said, “Acquisitions are more attractive than alliances,” setting the stage for more Indian companies to be taken over by their powerful European and American counterparts. But, today, Big Pharma thinks otherwise. With Indian drug …
Pharma cos worried that the dept is moving away from its stance on pricing of essential drugs. The Department of Pharmaceuticals has told a group of ministers that competition does not necessarily lead to reduction in medicine prices, raising concern among the industry that the department is moving away from …
The Andhra Pradesh Pollution Control Board has leveled allegations of pollution against various bulk drug units manufacturing drugs in excess of the permitted quantities. The charges also include pharmaceutical firms responsible for unauthorised manufacture of these drugs. Despite permission being taken to manufacture a certain quantity and category of drugs, …
A panel of ministers will meet on Wednesday to discuss the formula to cap the retail prices of 348 essential drugs and their combinations that seek to make medicines affordable without disturbing the growth of the industry. The group of ministers (GoM), headed by agriculture minister Sharad Pawar, will look …
MUMBAI: Life-saving drugs manufactured in the country may continue to cost more than the imported ones from China. In a major blow to the healthcare industry early this week, the Maharashtra Electricity Regulatory Commission (MERC) dismissed the petition of Indian bulk manufacturers of life-saving drugs, urging concessional power tariff to …
The compulsory licence issued to Natco for manufacture of the anti-cancer drug Nexavar is a landmark decision on many grounds – the first one in India since the 2005 amendment to the 1970 Patents Act and the fi rst in the world issued to a private party. There are some …
Indian drugmakers such as Zydus Cadila, Panacea Biotech and Serum Institute have resumed production of the swine flu vaccine as the once-pandemic disease threatens to strike again. The vaccine makers are anticipating an increase in demand because nearly 281 patients have tested positive to the dreaded H1N1 virus and 21 …
Health is a crucially important social and economic asset - a cornerstone for human development. Three of the eight Millennium Development Goals (MDGs) call for specific health improvements by 2015: reducing the child and maternal mortality and slowing the spread of HIV/AIDS, malaria and tuberculosis.
Ensuring that patients in the developing world get access to the medicines they need remains an unfulfilled desire. This is true in spite of the significant progress over the last decade in providing treatment to poor people suffering in particular from the "big three" pandemics, HIV/AIDS, malaria and tuberculosis. The …
